(Corrects analysts' estimate to 1.17 billion rupees from 1.12 billion rupees in fourth paragraph)
(Reuters) - India's Biocon Ltd reported a 47 percent rise in June-quarter profit on Thursday, helped by higher income from its biologics and research services businesses.
Net profit rose to 1.20 billion rupees ($17.48 million) for the quarter ended June 30, from 813 million rupees last year, India's largest biotechnology company said in a statement.
Revenue from operations rose 20.4 percent to 11.24 billion rupees.
Analysts on average were expecting a net profit of 1.17 billion rupees, according to Thomson Reuters I/B/E/S.
Also Read
($1 = 68.6550 Indian rupees)
(Reporting by Sharnya G and Chris Thomas in Bengaluru; Editing by Supriya Kurane)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app